“Uncovering Potential: Bronstein, Gewirtz & Grossman LLC Investigates Keros Therapeutics Inc. (KROS) and Urges Investors to Take Action”
New York Law Firm Investigating Potential Claims Against Keros Therapeutics, Inc. Investors Advised to Seek Additional Information New York, NY / ACCESS Newswire / January 23, 2025 / Bronstein, Gewirtz & Grossman, LLC is currently conducting an investigation into potential claims on behalf of purchasers of Keros Therapeutics, Inc. (“Keros” or “the Company”) (NASDAQ:KROS). If…